These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 33001349)
1. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients. Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349 [TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use. Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412 [TBL] [Abstract][Full Text] [Related]
3. The Prevalence of Hypomagnesemia in Hospitalized Type 2 Diabetic Patients Treated with Diuretics and/or Proton Pump Inhibitors. Mengesha B; Levi D; Kroonenberg M; Koren R; Golik A; Koren S Isr Med Assoc J; 2021 Apr; 23(4):245-250. PubMed ID: 33899358 [TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us? Luk CP; Parsons R; Lee YP; Hughes JD Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281 [TBL] [Abstract][Full Text] [Related]
5. The association of proton pump inhibitors and hypomagnesemia in the community setting. Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616 [TBL] [Abstract][Full Text] [Related]
6. Uses of proton pump inhibitors and hypomagnesemia. Gau JT; Yang YX; Chen R; Kao TC Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212 [TBL] [Abstract][Full Text] [Related]
7. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor. dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253 [TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862 [TBL] [Abstract][Full Text] [Related]
9. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users. Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358 [TBL] [Abstract][Full Text] [Related]
10. Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction? Abu-Amna M; Bar-Sela G Cancer Chemother Pharmacol; 2019 Mar; 83(3):545-550. PubMed ID: 30547192 [TBL] [Abstract][Full Text] [Related]
11. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort. Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924 [TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors and Hypomagnesemia in Older Inpatients: An Observational Study. Anna Vermeulen Windsant-van den Tweel AM; Derijks HJ; Gadiot NPPM; Keijsers CJPW Sr Care Pharm; 2022 Dec; 37(12):623-630. PubMed ID: 36461136 [No Abstract] [Full Text] [Related]
16. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease. Hughes J; Y Y Chiu D; Kalra PA; Green D PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851 [TBL] [Abstract][Full Text] [Related]
17. Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis. Liao S; Gan L; Mei Z Medicine (Baltimore); 2019 Mar; 98(13):e15011. PubMed ID: 30921222 [TBL] [Abstract][Full Text] [Related]
18. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study. Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584 [TBL] [Abstract][Full Text] [Related]
19. Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia. Kim S; Lee H; Park CH; Shim CN; Lee HJ; Park JC; Shin SK; Lee SK; Lee YC; Kim HY; Kang DR Am J Ther; 2015; 22(1):14-21. PubMed ID: 23846522 [TBL] [Abstract][Full Text] [Related]
20. Hypomagnesemia associated with a proton pump inhibitor. Matsuyama J; Tsuji K; Doyama H; Kim F; Takeda Y; Kito Y; Ito R; Nakanishi H; Hayashi T; Waseda Y; Tsuji S; Takemura K; Yamada S; Okada T; Kanaya H Intern Med; 2012; 51(16):2231-4. PubMed ID: 22892510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]